0001145549-21-035844.txt : 20210611 0001145549-21-035844.hdr.sgml : 20210611 20210611155345 ACCESSION NUMBER: 0001145549-21-035844 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210611 DATE AS OF CHANGE: 20210611 EFFECTIVENESS DATE: 20210611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: J.P. Morgan Access Multi-Strategy Fund II CENTRAL INDEX KEY: 0001524115 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22575 FILM NUMBER: 211011179 BUSINESS ADDRESS: STREET 1: 277 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10172 BUSINESS PHONE: 800-480-4111 MAIL ADDRESS: STREET 1: 277 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10172 N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001524115 XXXXXXXX true false false N-2 J.P. Morgan Access Multi-Strategy Fund II 811-22575 0001524115 5493001M0PQV86T26248 277 Park Avenue New York 10172 US-NY US 8004804111 J.P. Morgan Investment Management Inc. (JPMIM) 383 Madison Ave New York 10179 800-343-1113 Records related to its function as Investment Adivser & Administrator Services J.P. Morgan Private Investments Inc. 383 Madison Ave New York 10179 212-464-2070 Records related to its function as Sub-Adivser BNY Mellon Investment Servicing (US) Inc. 400 Bellevue Parkway Wilmington 19809 877-431-1973 Records related to its function as sub-administrator and custodian N N N-2 Y John F. Finn N/A N Kathleeen M. Gallagher N/A N Dennis P. Harrington N/A N Frankie D. Hughes N/A N Raymond Kanner N/A N Mary E. Martinez N/A N Marilyn McCoy N/A N Dr. Robert A. Oden, Jr. N/A N Marian U. Pardo N/A N Stephen P. Fisher N/A N Stephen M. Ungerman 002315698 277 Park Avenue New York 10172 XXXXXX N N N N N N N J.P. Morgan Securities Inc. 8-36950 N/A N/A Y N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N N N N J.P. Morgan Access Multi-Strategy Fund II 5493001M0PQV86T26248 N 0 0 0 Fund of Funds Y N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 23c-1 (17 CFR 270.23c-1) Rule 32a-4 (17 CFR 270.32a-4) Y N N N J.P. Morgan Investment Management Inc. 801-21011 000107038 549300W78QHV4XMM6K69 N J.P. Morgan Private Investments Inc. 801-41088 000110186 549300JJOCEDFCUF5Y75 N BNY Mellon Investment Servicing (US) Inc. 084-01761 549300CFZQLI9QMJ1Z03 N N N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N BNY Mellon Investment Servicing (US) Inc. 549300CFZQLI9QMJ1Z03 N N N BNY Mellon Investment Servicing (US) Inc. 549300CFZQLI9QMJ1Z03 N N N J.P. Morgan Securities Inc. 008-36950 001818718 ZBUT11V806EZRVTWT807 0.0 0.000000000000 0.000000000000 N 76017505.000000000000 Other Shares Shares N N Other Shares N N N 1.000000000000 1.780000000000 N/A 15.810000000000 true INTERNAL CONTROL RPT 2 ricii_n-cen.htm INTERNAL CONTROL LETTER

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of J.P. Morgan Access Multi-Strategy Fund II

In planning and performing our audit of the financial statements of J.P. Morgan Access Multi-Strategy Fund II (the “Fund”) as of and for the year ended March 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of March 31, 2021.

This report is intended solely for the information and use of the Board of Trustees of J.P. Morgan Access Multi-Strategy Fund II and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

New York, New York

May 28, 2021